Myrna R Nahas

Years Active: 2018-2019
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Myrna R Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, Leandra Cole, Athalia R Pyzer, Eleni Anastasiadou, Anna Sergeeva, Adam Ephraim, Abigail Washington, Shira Orr, Malgorzata McMasters, Matthew Weinstock, Salvia Jain, Rebecca K Leaf, Haider Ghiasuddin, Maryam Rahimian, Jessica Liegel, Jeffrey J Molldrem, Frank Slack, Donald Kufe, David Avigan
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine. British journal of haematology 185 (4) (2019)
Myrna R Nahas, Robert J Soiffer, Haesook T Kim, Edwin P Alyea, Jon Arnason, Robin Joyce, Joseph H Antin, Vincent T Ho, Dina Stroopinsky, Shuli Li, James D Levine, Malgorzata McMasters, Salvia Jain, Ayad Hamdan, Dimitrios Tzachanis, Mary Paty Bryant, Emma K Logan, Josie Bazemore, Jeremy Stewart, Amy Joyce, Susan Stephenson, Abigail Washington, Leandra Cole, Athalia Pyzer, Rebecca Karp Leaf, David E Avigan, Jacalyn Rosenblatt
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease. Blood 131 (25) (2018)

Myrna R Nahas.css-eqlu8i{font-size:small;padding-left:4px;}